- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
U.S. Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
14
High return on equity, past performance and sound balance sheet.
14 companies
Johnson & Johnson
Market Cap: US$368.6b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
JNJ
US$152.61
7D
2.0%
1Y
1.9%
Waters
Market Cap: US$20.7b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$348.46
7D
-0.9%
1Y
3.5%
Medpace Holdings
Market Cap: US$8.5b
Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
MEDP
US$293.03
7D
-1.1%
1Y
-25.0%
Exelixis
Market Cap: US$11.9b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$42.86
7D
-7.3%
1Y
110.0%
Agilent Technologies
Market Cap: US$31.1b
Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
A
US$109.68
7D
-2.4%
1Y
-27.1%
Catalyst Pharmaceuticals
Market Cap: US$3.0b
A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.
CPRX
US$24.11
7D
1.4%
1Y
51.4%
Niagen Bioscience
Market Cap: US$799.6m
Operates as a bioscience company engages in developing healthy aging products.
NAGE
US$10.16
7D
-3.2%
1Y
212.6%
China SXT Pharmaceuticals
Market Cap: US$26.6m
A pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China.
SXTC
US$1.61
7D
3.2%
1Y
-81.0%
Puma Biotechnology
Market Cap: US$166.3m
A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.
PBYI
US$3.25
7D
-0.9%
1Y
-18.5%
CytomX Therapeutics
Market Cap: US$321.4m
Operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment.
CTMX
US$2.13
7D
6.5%
1Y
16.4%
BioStem Technologies
Market Cap: US$200.4m
A life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.
BSEM
US$12.00
7D
-0.02%
1Y
61.0%
Avalo Therapeutics
Market Cap: US$41.0m
A clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation in the Unites States.
AVTX
US$3.91
7D
1.3%
1Y
-64.9%
Champions Oncology
Market Cap: US$82.0m
A technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States.
CSBR
US$5.81
7D
-7.5%
1Y
25.5%
Earth Science Tech
Market Cap: US$44.1m
Focuses on health and wellness industry.
ETST
US$0.14
7D
-15.0%
1Y
-42.8%